103
Participants
Start Date
October 31, 2005
Primary Completion Date
July 31, 2007
Study Completion Date
October 31, 2009
Bendamustine HCl
Dose of 120 mg/m2 on Day 1 and Day 2 of each treatment cycle (every 21 days). Patients who are continuing to experience clinical benefit at Cycle 6, as assessed by the investigator, may receive up to 2 additional cycles, to a maximum of 8 cycles.
Weill Cornell Cancer Care Center, New York
Roswell Park Cancer Institute, Buffalo
Interlakes Foundation, Inc., Rochester
University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester
Georgetown University Medical Center, Washington D.C.
University of Virginia Cancer Center, Charlottesville
Duke University School of Medicine, Durham
University of Alabama Birmingham, Birmingham
Sarah Cannon Research Institute, Nashville
The West Clinic/ACORN, Memphis
Markey Cancer Center, University of Kentucky Medical Center, Lexington
The Cleveland Clinic Foundation Taussig Cancer Center, Cleveland
Indiana Oncology Hematology Consultants, A Division of AHN, Indianapolis
University of Michigan Cancer Center, Ann Arbor
Henry Ford Health System, Detroit
University of Wisconsin, Madison
Rush University Medical Center, Chicago
Washington University School of Medicine in St. Louis, St Louis
LSU Health Sciences Center, Feist Weiller Cancer Center, Shreveport
Arlington Cancer Center, Arlington
University of Colorado Cancer Center, Aurora
Arizona Cancer Center, Tucson
University of New Mexico Cancer Research and Treatment Center, Albuquerque
Nevada Cancer Institute, Las Vegas
USC/Norris Cancer Hospital, Los Angeles
Tower Hematology and Oncology Medical Group, Beverly Hills
Moores UCSD Cancer Center, La Jolla
Comprehensive Cancer Center - Desert Regional Medical Center, Palm Springs
Stanford University Division of Oncology, Stanford
Alta Bates Comprehensive Cancer Center, Berkeley
Yale University School of Medicine, New Haven
Dana Farber Cancer Institute, Boston
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency, Vancouver
Queen Elizabeth Health Sciences Centre, Halifax
Ottawa Hospital - General Campus, Ottawa
Hopital Notre-Dame du CHUM, Montreal
Hopital du Sacre Couer de Montreal, Montreal
Saskatchewan Cancer Center Agency, Saskatoon
Hospital Espanol Auxilio Mutuo, Auxilio Mutuo Cancer Center, San Juan
Lead Sponsor
Cephalon
INDUSTRY